PharmaPrimes provides advanced bioanalytical services supporting pharmaceutical and biopharmaceutical development programs.
Our laboratories provide regulatory-focused bioanalysis for small molecules, peptides, monoclonal antibodies, therapeutic proteins, and other biologics.
Our integrated services support preclinical studies, clinical trials, bioequivalence studies, and biosimilar development programs.
Customized bioanalytical method development for challenging drug molecules and complex biological matrices.
PharmaPrimes has documented experience with challenging metabolic drugs and GLP-1 analogues, including:
Bioanalytical methods are validated according to applicable ICH M10 Bioanalytical Method Validation requirements.
Integrated clinical and bioanalytical support for BE/BA studies and pharmacokinetic evaluation.
Analytical characterization, purity and heterogeneity assessment, glycosylation profiling, biological activity, process-related impurity testing, clinical PK, and immunogenicity support.
Hospital-based clinical research through the PharmaPrimes Clinical Research Center located within Jordan Hospital in Amman.
Tell us about your molecule, matrix, and study design, and our bioanalytical scientists will propose a method development and validation approach.
